Semaglutide for Post-Smoking Cessation Weight Management — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Semaglutide for Post-Smoking Cessation Weight Management — Stella

View on ClinicalTrials.gov

Recruiting

Back to Obesity trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

The University of Texas at Austin, Austin, Texas

The University of Texas Health Science Center at Houston, Houston, Texas

Key details

Phase

Safety & dosing

Sponsor

The University of Texas Health Science Center, Houston

Enrollment target

~197 participants

Started

April 2024

Primary completion

July 2026

Age range

18 Years – 75 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.